| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $440.5M | +38.2% |
| Cost of Revenue | $523.9M | +16.0% |
| R&D Expense | $5.4M | +62.2% |
| SG&A Expense | $103.4M | +38.1% |
| Operating Income | $21.8M | +42.2% |
| Interest Expense | $118K | +91.9% |
| Pre-tax Income | $22.8M | +15.1% |
| Income Tax | -$8.0M | -1393.1% |
| Net Income | $34.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157.3M | -10.4% |
| Current Assets | $271.1M | +5.9% |
| Total Assets | $393.3M | +27.0% |
| Current Liabilities | $100.2M | +73.1% |
| Total Liabilities | $114.4M | +38.5% |
| Stockholders' Equity | $273.2M | +24.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.9M | +1582.5% |
| Capital Expenditures | $3.2M | -33.5% |
| Investing Cash Flow | -$38.4M | -347.6% |
| Financing Cash Flow | -$6.2M | -104.0% |
| Free Cash Flow | $25.7M | +480.0% |
| +80.3% |
| EPS (Basic) | $0.34 | +13.3% |
| EPS (Diluted) | $0.34 | +36.0% |